mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.04 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.04 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.05 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.05 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |